No Data
No Data
Speee, Astellas Pharma, etc. (Part 2)
<4499> Speee Inc. Rakuten Securities, Inc. shareholding ratio: 5.08% → 0.51%. Reporting obligation date: June 28, 2024.<4503> Astellas Pharma Inc. BlackRock Japan Co., Ltd. shareholding ratio: 8.52% → 7.50%. Reporting obligation date: June 28, 2024.<4674> Cresco Ltd. Iwasaki Corporation shareholding ratio: 20.36% → 20.36%.
Hikari Tsushin increases its stake in YAMADA Consulting Group(4792.JP) to 11.59%
On Jul 3, Hikari Tsushin and related parties submitted the Change Report to Ministry of Finance. The report shows that Hikari Tsushin and related parties increased their holdings in $YAMADA Consulting
YAMADA Consulting Group: Interim report
YAMADA Consulting Group: Confirmatory letter.
YAMADA Consulting Group: Securities report - 35th period (April 1, 2023 - March 31, 2024).
Yamada Consulting Research Memo (6): An annual dividend of 76.0 yen will be implemented for the fiscal year ending March 2024.
Yamada Consulting Group <4792> recognizes that returning profits to shareholders is one of the important management issues and has a basic policy of "maintaining a high and stable dividend". Specific indicators aim for a dividend payout ratio of 50% and a DOE (stock dividend payout ratio) of 5%. Taking into account the profit level and financial situation of the group, the interim dividend for the March 2024 term is 33.0 yen and the year-end dividend is 43.0 yen (in May 2024, in May 2023)
No Data